Shanghai Fosun Pharmaceutical (Group) Co., Ltd

China

Back to Profile

1-10 of 10 for Shanghai Fosun Pharmaceutical (Group) Co., Ltd and 1 subsidiary Sort by
Query
Excluding Subsidiaries
Aggregations Reset Report
IP Type
        Trademark 7
        Patent 3
Jurisdiction
        World 7
        United States 2
        Canada 1
Owner / Subsidiary
[Owner] Shanghai Fosun Pharmaceutical (Group) Co., Ltd 10
Chongqing Pharmaceutical Research Institute Co., Ltd. 1
Date
2024 4
2023 1
Before 2020 5
IPC Class
A61P 35/00 - Antineoplastic agents 2
A61K 31/425 - Thiazoles 1
A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline 1
A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole 1
A61K 9/08 - Solutions 1
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 5
35 - Advertising and business services 5
10 - Medical apparatus and instruments 4
40 - Treatment of materials; recycling, air and water treatment, 4
42 - Scientific, technological and industrial services, research and design 3
Status
Pending 1
Registered / In Force 9

1.

FOSUN PHARMA

      
Application Number 1816979
Status Registered
Filing Date 2024-07-05
Registration Date 2024-07-05
Owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Antiseptics; chemico-pharmaceutical preparations; anaesthetics; pharmaceutical preparations; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes; biological preparations for medical purposes; medicines for human purposes; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes. Testing apparatus for medical purposes; medical apparatus and instruments. Retail or wholesale services for medical supplies; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations; marketing; sales promotion for others. Drug development; pharmaceutical research; clinical trials.

2.

TRICYCLIC COMPOUND AS ATR KINASE INHIBITOR

      
Application Number CN2024085457
Publication Number 2024/208177
Status In Force
Filing Date 2024-04-02
Publication Date 2024-10-10
Owner SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (China)
Inventor
  • Liu, Peng
  • Hu, Bin
  • Zheng, Jiamin
  • Zhang, Zhisen
  • Yu, Huaxing
  • Ding, Xiao
  • Yan, Shangjun

Abstract

The present application relates to a compound as represented by formula I, an isomer, an isotope marker or a pharmaceutically acceptable salt thereof, and the uses thereof as an ATR kinase inhibitor and for treating cancers, wherein each group is as defined herein.

IPC Classes  ?

  • C07D 487/06 - Peri-condensed systems
  • C07D 498/04 - Ortho-condensed systems
  • C07D 471/16 - Peri-condensed systems
  • A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
  • A61P 35/00 - Antineoplastic agents

3.

AZAARYL COMPOUND AND USE THEREOF AS LSD1 INHIBITOR

      
Application Number CN2024085484
Publication Number 2024/208187
Status In Force
Filing Date 2024-04-02
Publication Date 2024-10-10
Owner SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (China)
Inventor
  • Hu, Bin
  • Liu, Peng
  • Zhang, Meng
  • Zheng, Min
  • Lu, Hongfu
  • Ding, Xiao
  • Yan, Shangjun

Abstract

The present invention relates to a compound as represented by formula I, a pharmaceutically acceptable salt, an isomer, or an isotope marker thereof. The compound can be used as an LSD1 inhibitor, and can also be used for preventing or treating tumors such as hematological neoplasms and small cell lung cancer.

IPC Classes  ?

  • C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
  • C07D 471/04 - Ortho-condensed systems
  • C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
  • C07D 487/04 - Ortho-condensed systems
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline

4.

FOSUN PHARMA

      
Serial Number 79407348
Status Pending
Filing Date 2024-07-05
Owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)
NICE Classes  ?
  • 35 - Advertising and business services
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Retail or wholesale services for medical supplies; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations; marketing; sales promotion for others. Antiseptics; chemico-pharmaceutical preparations; anaesthetics; pharmaceutical preparations; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes; biological preparations for medical purposes; medicines for human purposes; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes. Testing apparatus for medical purposes; medical apparatus and instruments. Drug development; pharmaceutical research; clinical trials.

5.

FOSUN PHARMA

      
Application Number 1710261
Status Registered
Filing Date 2022-09-28
Registration Date 2022-09-28
Owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical genetic characteristics test reagents; antiseptics; bath preparations for medical purposes; chemico-pharmaceutical preparations; anaesthetics; pharmaceutical preparations; vaccines; medicine cases, portable, filled; lotions for pharmaceutical purposes; liniments; nutritive substances for microorganisms; sedatives; styptic preparations; chemical preparations for pharmaceutical purposes; medicinal drinks; medicated soap; medicines in form of tablet form; medicinal oil solutions; prepared Chinese medicines; tonics [medicines]; immunostimulants; liquid medicines; adhesive patches for medical purposes; blood products; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; slimming pills; injectable medicinal solutions; medicinal ointments; biochemical medicines; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of hypercholesteremia; nutraceutical preparations for therapeutic or medical purposes; tinctures for medical purposes; active pharmaceutical ingredient; bacteriological preparations for medical purposes; pharmaceutical preparations for the treatment of hyperlipidemia; oral care preparations, medicated; reagents for use in medical genetic testing; medicinal alcohol; balsamic preparations for medical purposes; capsules for medicines; vitamin preparations; disinfectants; drugs for medical purposes; medicinal tea; suppositories; biological preparations for medical purposes; medicines for human purposes; chemical reagents for medical or veterinary purposes; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; medical immunoassay reagents; chemical preparations for the diagnosis of pregnancy; pharmaceutical preparations for skin care; diagnostic preparations for medical purposes; antibiotics; dietetic foods adapted for medical purposes; nutritional supplements; food for babies; dietetic beverages adapted for medical purposes; infant formula; depuratives; medicines for veterinary purposes; pesticides; biocides; bandages for dressings; babies' diapers; dressings, medical; wadding for medical purposes; pants, absorbent, for incontinence; medicinal health kit; eyepatches for medical purposes; adhesive tapes for medical purposes; tissues impregnated with pharmaceutical lotions; disinfectant wipes; surgical glues; dental abrasives; teeth filling material; dental mastics; alloys of precious metals for dental purposes; diapers for pets. Retail or wholesale services for medical supplies; retail or wholesale services for sanitary preparations; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations. Grinding; processing of medicinal materials; services of a dental technician; processing of chemical reagents. Drug development; pharmaceutical product evaluation; pharmaceutical research; conducting early evaluations in the field of new pharmaceuticals; scientific research and development; scientific investigations for medical purposes; technological research; pharmaceutical research; chemical research; cosmetic research; biochemical research and analysis; biological research; clinical trials; bacteriological research; biological cloning services; DNA screening for scientific research purposes; bacteriological research and analysis; material testing.

6.

FOSUN PHARMA

      
Application Number 1290694
Status Registered
Filing Date 2015-10-27
Registration Date 2015-10-27
Owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd (China)
NICE Classes  ?
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,

Goods & Services

Sales promotion services for third parties; commercial administration of the licensing of the goods and services of others; presentation of goods on communication media, for retail purposes. Medicinal materials processing; processing of chemical reagents.

7.

FOSUN PHARMA

      
Serial Number 79183886
Status Registered
Filing Date 2015-10-27
Registration Date 2018-11-27
Owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd (China)
NICE Classes  ?
  • 35 - Advertising and business services
  • 40 - Treatment of materials; recycling, air and water treatment,

Goods & Services

Sales promotion services for third parties; business assistance, advisory and consulting services in the field of commercial administration of the licensing of the goods and services of others; presentation of goods on all forms of media communications stations, systems, networks, and services for the purpose of promoting the goods and services of others Medicinal materials processing, comprising slicing, steaming and soaking of medicinal materials; processing of chemical reagents used for preparation, production and application guidance of polymerace chain reaction (PCR) agents for testing of samples such as serum, sputum and secretions as well as for preparation, production and application guidance of biochemical agents used in testing of samples such as blood and body fluids

8.

A PHARMACEUTICAL COMPOSITION FOR TREATING GOUT AND ITS PREPARATION AND USE

      
Application Number CN2006002827
Publication Number 2007/048332
Status In Force
Filing Date 2006-10-23
Publication Date 2007-05-03
Owner
  • CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (China)
  • SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD (China)
Inventor
  • Deng, Jie
  • Fan, Bin
  • Mu, Caihua
  • Zou, Yanye

Abstract

A pharmaceutical composition for treating gout and its application in preparation of medicines for treating gout are provided. The said pharmaceutical composition comprises effective amount of febuxostat or its pharmaceutical salts or its solvates and a uric acid eliminant.

IPC Classes  ?

9.

FOSUN

      
Application Number 875045
Status Registered
Filing Date 2005-09-19
Registration Date 2005-09-19
Owner Shanghai Fosun Pharmaceutical (Group) CO., LTD (China)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 40 - Treatment of materials; recycling, air and water treatment,

Goods & Services

Medical paste; chemico-pharmaceutical preparations; medicines for human purposes; dressings (medical); tissue paper impregnated with disinfectants; teeth filling material; medicinal drinks; adhesive tapes for medical purposes; dietetic food preparations adapted for medical purposes; solutions for contact lenses. Dental apparatus; hearing aids for the deaf; contraceptives, non-chemical; surgical implants; orthopedic articles; suture materials; furniture especially made for medical purposes; medical apparatus and instruments. Processing of medicinal materials; processing and handling of chemical reagents.

10.

FOSUN

      
Application Number 127844100
Status Registered
Filing Date 2005-11-04
Registration Date 2011-05-04
Owner SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD (China)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Surgical and topical anaesthetics; analgesics; antipyretics; non-steroidal anti-inflammatory medicines; medicines used to treat gout; medicines used to treat disease modifying agents in rheumatoid disorders;antiallergics; medicine used in anaphylaxis; antidotes to counteract poisons; anticonvulsants; anti-epileptics; anti-infectives; anti-migraine medicine; anti-neoplastic; immunosuppressives used in palliative care; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; herbal supplements and pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; hormones for humans, namely, human growth hormones, hormone replacement therapy preparations; contraceptives, namely, condoms, diaphragms, foams, oral, sponges, spermicides; opthalmological preparations; medicine acting on the respiratory tract; vitamins; minerals; PCR reagent used to test sputum; PCR reagent used in the hepatis; PCR reagent used in respiratory disease; PCR reagent used in venereal disease; PCR reagent used in bacterial disease; chemical preparations used to test blood; chemical preparations used to test sputum; pharmaceutical preparations for the treatment of blood disorders, the treatment of cancer, headaches, headaches, immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, infectious diseases, namely, respiratory infections, eye infections, inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the respiratory system; pharmaceutical preparations for use in gastroenterology.